Ceesay Abraham sells RAPP shares
- Sold 3,375 shares at $32.03 on 10/06/2026
- Sold 1,147 shares at $30.66 on 10/07/2026
- Owns 452,245 shares directly
Abraham Ceesay, reporting
RAPP
Rapport Therapeutics, Inc. SEC filings
Every EDGAR filing for Rapport Therapeutics, Inc. (RAPP), newest first, with AI summaries and stories.
- Ticker
- RAPP
- CIK
- 2012593
- Latest filing
- Oct 8
Next: earnings expected ~Nov 9 · 10-Q expected ~Nov 9 (deadline Nov 16)
Insider activity
No open-market insider buys in the last 30 days.
Also: 7 open-market sales ($562K).
Filings
4Rapport Therapeutics, Inc.RAPPLIVE 144Rapport Therapeutics, Inc.RAPPLIVE RAPP Ceesay files Form 144 on 10/06/2026
- Filer: Abraham N. Ceesay
- Shares to sell: 39,470
- Acquired as compensation on 12/02/2022
Abraham Ceesay, reporting
4Rapport Therapeutics, Inc.RAPPLIVE Cheryl Gault, insider filing for RAPP
Cheryl Gault
144Rapport Therapeutics, Inc.RAPPLIVE Cheryl Gault, planned sale of RAPP shares
Cheryl Gault, reporting
4Rapport Therapeutics, Inc.RAPPLIVE Abraham Ceesay, insider filing for RAPP
Abraham Ceesay, reporting
4Rapport Therapeutics, Inc.RAPPLIVE Abraham Ceesay, insider filing for RAPP
Abraham Ceesay, reporting
4Rapport Therapeutics, Inc.RAPPLIVE 2 insider filings
Abraham Ceesay, insider filing for RAPP
Show all 2
- 4Insider filing for RAPP
- 4Insider filing for RAPP
Abraham Ceesay, reporting
144Rapport Therapeutics, Inc.RAPPLIVE Krishnaswamy Yeleswaram, planned sale of RAPP shares
Krishnaswamy Yeleswaram, reporting
144Rapport Therapeutics, Inc.RAPPLIVE Krishnaswamy Yeleswaram, planned sale of RAPP shares
Krishnaswamy Yeleswaram, reporting
4Rapport Therapeutics, Inc.RAPPLIVE Krishnaswamy Yeleswaram, insider filing for RAPP
Krishnaswamy Yeleswaram, reporting
144Rapport Therapeutics, Inc.RAPPLIVE Krishnaswamy Yeleswaram, planned sale of RAPP shares
Krishnaswamy Yeleswaram, reporting
SCHEDULE 13G/ARapport Therapeutics, Inc.RAPPLIVE Ownership stake disclosure by Third Rock Ventures V, L.P. (amended)
Third Rock Ventures V, L.P., filed by
SCHEDULE 13G/ARapport Therapeutics, Inc.RAPPLIVE Ownership stake disclosure by Cormorant Asset Management, LP (amended)
Cormorant Asset Management, LP, filed by
4Rapport Therapeutics, Inc.RAPPLIVE Abraham Ceesay, insider filing for RAPP
Abraham Ceesay, reporting
SCHEDULE 13G/ARapport Therapeutics, Inc.RAPPLIVE Ownership stake disclosure by Capital International Investors (amended)
Capital International Investors, filed by
8-KRapport Therapeutics, Inc.RAPPLIVE 10-QRapport Therapeutics, Inc.RAPPLIVE 4Rapport Therapeutics, Inc.RAPPLIVE Abraham Ceesay, insider filing for RAPP
Abraham Ceesay, reporting
4Rapport Therapeutics, Inc.RAPPLIVE Abraham Ceesay, insider filing for RAPP
Abraham Ceesay, reporting
4Rapport Therapeutics, Inc.RAPPLIVE 2 insider filings
Cheryl Gault, insider filing for RAPP
Show all 2
- 4Insider filing for RAPP
- 4Insider filing for RAPP
Cheryl Gault, reporting
144Rapport Therapeutics, Inc.RAPPLIVE Cheryl Gault, planned sale of RAPP shares
Cheryl Gault, reporting
144Rapport Therapeutics, Inc.RAPPLIVE Abraham Ceesay, planned sale of RAPP shares
Abraham Ceesay, reporting
4Rapport Therapeutics, Inc.RAPPLIVE 8 insider filings
John Maraganore, insider filing for RAPP
Show all 8
- 4Insider filing for RAPP
- 4Insider filing for RAPP
- 4Insider filing for RAPP
- 4Insider filing for RAPP
- 4Insider filing for RAPP
- 4Insider filing for RAPP
- 4Insider filing for RAPP
- 4Insider filing for RAPP
John Maraganore, reporting
8-KRapport Therapeutics, Inc.RAPPLIVE 4Rapport Therapeutics, Inc.RAPPLIVE Third Rock Ventures V, L.P., insider filing for RAPP
Third Rock Ventures V, L.P., reporting · Third Rock Ventures VI, L.P., reporting · +4 more
144Rapport Therapeutics, Inc.RAPPLIVE Third Rock Ventures V, L.P., planned sale of RAPP shares
Third Rock Ventures V, L.P., reporting
SCHEDULE 13G/ARapport Therapeutics, Inc.RAPPLIVE Ownership stake disclosure by Cormorant Asset Management, LP (amended)
Cormorant Asset Management, LP, filed by
4Rapport Therapeutics, Inc.RAPPLIVE Third Rock Ventures V, L.P., insider filing for RAPP
Third Rock Ventures V, L.P., reporting · Third Rock Ventures VI, L.P., reporting · +4 more
4Rapport Therapeutics, Inc.RAPPLIVE Third Rock Ventures V, L.P., insider filing for RAPP
Third Rock Ventures V, L.P., reporting · Third Rock Ventures VI, L.P., reporting · +4 more
144Rapport Therapeutics, Inc.RAPPLIVE Third Rock Ventures V, L.P., planned sale of RAPP shares
Third Rock Ventures V, L.P., reporting
144Rapport Therapeutics, Inc.RAPPLIVE Third Rock Ventures V, L.P., planned sale of RAPP shares
Third Rock Ventures V, L.P., reporting
144Rapport Therapeutics, Inc.RAPPLIVE Third Rock Ventures V, L.P., planned sale of RAPP shares
Third Rock Ventures V, L.P., reporting
10-QRapport Therapeutics, Inc.RAPPLIVE 8-KRapport Therapeutics, Inc.RAPPLIVE ARSRapport Therapeutics, Inc.RAPPLIVE DEFA14ARapport Therapeutics, Inc.RAPPLIVE DEF 14ARapport Therapeutics, Inc.RAPPLIVE 4Rapport Therapeutics, Inc.RAPPLIVE Third Rock Ventures V, L.P., insider filing for RAPP
Third Rock Ventures V, L.P., reporting · Third Rock Ventures VI, L.P., reporting · +4 more
4Rapport Therapeutics, Inc.RAPPLIVE Krishnaswamy Yeleswaram, insider filing for RAPP
Krishnaswamy Yeleswaram, reporting
8-KRapport Therapeutics, Inc.RAPPLIVE 144Rapport Therapeutics, Inc.RAPPLIVE Krishnaswamy Yeleswaram, planned sale of RAPP shares
Krishnaswamy Yeleswaram, reporting